Increased expression of fibrillin-1 in human corneas with bullous keratopathy

Cornea

Volumn 17, Issue 3, 1998, Pages 309-314

  Ljubimov, Alexander V ^a   Saghizadeh, Mehrnoosh ^a   Spirin, Konstantin S ^a   Mecham, Robert P ^b   Sakai, Lynn Y ^c   Kenney, M Cristina ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SHRINERS HOSPITAL FOR CHILDREN   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Basement membrane; Bullous keratopathy; Extracellular matrix; Fibrillin 1; Fibrillin 2; Immunofluorescence; RT PCR

Indexed keywords

COLLAGEN; FIBRILLIN; MESSENGER RNA;

APHAKIA; ARTICLE; BOWMAN MEMBRANE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA LIMBUS; CORNEA STROMA; DESCEMET MEMBRANE; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; KERATOPATHY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPHAKIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

EID: 0031971895     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199805000-00012     Document Type: Article

References (54)

1. Lois N, Kowal VO, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1989-1995. Cornea 1997; 16:623-9.
2. Liu E, Slomovic AR. Indications for penetrating keratoplasty in Canada, 1986-1995. Cornea 1997;16:414-9.
3. Sasaki Y, Tuberville AW, Wood TO, McLaughlin BJ. Freeze fracture study of human corneal endothelial dysfunction. Invest Ophthalmol Vis Sci 1986;27:480-5.
4. McCartney MD, Robertson DP, Wood TO, McLaughlin BJ. ATPase pump site density in human dysfunctional corneal endothelium. Invest Ophthalmol Vis Sci 1987;28:1955-62.
5. Liu GJ, Okisaka S, Mizukawa A, Momose A. Histopathological study of pseudophakic bullous keratopathy developing after anterior chamber of iris-supported intraocular lens implantation. Jpn J Ophthalmol 1993;37:414-25.
6. Numa A, Nakamura J, Takashima M, Kani K. Long-term corneal endothelial changes after intraocular lens implantation: anterior vs posterior chamber lenses. Jpn J Ophthalmol 1993;37:78-87.
7. Ljubimov AV, Burgeson RE, Butkowski et al. Extracellular matrix alterations in human corneas with bullous keratopathy. Invest Ophthalmol Vis Sci 1996;37:997-1007.
8. Kenney MC, Nesburn AB, Burgeson RE, Butkowski RJ, Ljubimov AV. Abnormalities of the extracellular matrix in keratoconus corneas. Cornea 1997;16:345-51.
9. Wheatley HM, Traboulsi EI, Flowers BE, et al. Immunohistochemical localization of fibrillin in human ocular tissues: relevance to the Marfan syndrome. Arch Ophthalmol 1995;113:103-9.
10. Azar DT, Gipson IK. Immunolocalization of fibrillin and type VII collagen in keratoconus corneas: ARVO abstracts. Invest Ophthalmol Vis Sci 1990;31:100.
11. Zaidi TS, Hasan A, Baum J, Panjwani N. Localization of fibrillin in normal human and bovine corneas: ARVO abstracts. Invest Ophthalmol Vis Sci 1991;32:875.
12. Schlötzer-Schrehardt U, von der Mark K, Sakai LY, Naumann GO. Increased extracellular deposition of fibrillin-containing fibrils in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 1997;38: 970-84.
13. Sakai LY, Keene DR, Engvall E. Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986;103:2499-509.
14. Zhang H, Apfelroth SD, Hu W, et al. Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 1994;124:855-63.
15. Ramirez F, Pereira L, Zhang H, Lee B. The fibrillin-Marfan syndrome connection. Bioessays 1993;15:589-94.
16. Ramirez F. Fibrillin mutations in Marfan syndrome and related phenotypes. Curr Opin Genet Dev 1996;6:309-15.
17. Dietz HC, Ramirez F, Sakai LY. Marfan's syndrome and other microfibrillar diseases. Adv Hum Genet 1994;22:153-86.
18. Corson GM, Chalberg SC, Dietz HC, Charbonneau NL, Sakai LY. Fibrillin binds calcium and is coded by cDNAs that reveal a multidomain structure and alternatively spliced exons at the 5′ end. Genomics 1993;17:476-84.
19. Pereira L, D'Alessio M, Ramirez F, et al. Genomic organization of the sequence coding for fibrillin, the defective gene product in Marfan syndrome. Hum Mol Genet 1993;2:961-8.
20. Reinhardt DP, Ono RN, Sakai LY. Calcium stabilizes fibrillin-1 against proteolytic degradation. J Biol Chem 1997;272:1231-6.
21. Reinhardt DP, Mechling DE, Boswell BA, Keene DR, Sakai LY, Bachinger HP. Calcium determines the shape of fibrillin. J Biol Chem 1997;272:7368-73.
22. Pfaff M, Reinhardt DP, Sakai LY, Timpl R. Cell adhesion and integrin binding to recombinant human fibrillin-1. FEBS Lett 1996; 384:247-50.
23. Sakamoto H, Broekelmann T, Cheresh DA, Ramirez F, Rosenbloom J, Mecham RP. Cell-type specific recognition of RGD- and non-RGD-containing cell binding domains in fibrillin-1. J Biol Chem 1996;271:4916-22.
24. Maslen CL, Corson GM, Maddox BK, Glanville RW, Sakai LY. Partial sequence of a candidate gene for the Marfan syndrome. Nature 1991;352:334-7.
25. Dietz HC, Saraiva JM, Pyeritz RE, Cutting GR, Francomano CA. Clustering of fibrillin (FBN-1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum Mutat 1992;1:366-74.
26. Tynan K, Comeau K, Pearson M, et al. Mutation screening of complete fibrillin-1 coding sequence: report of five new mutations, including two in 8-cysteine domains. Hum Mol Genet 1993;2: 1813-21.
27. Raghunath M, Kielty CM, Kainulainen K, Child A, Peltonen L, Steinmann B. Analysis of truncated fibrillin caused by a 366 bp deletion in the FBN1 gene resulting in Marfan syndrome. Biochem J 1994;302:889-96.
28. Kainulainen K, Karttunen L, Puhakka L, Sakai L, Peltonen L. Mutations in the fibrillin gene responsible for dominant ectopia lentis and neonatal Marfan syndrome. Nat Genet 1994;6:64-9.
29. Kielty CM, Davies SJ, Phillips JE, Jones CJ, Shuttleworth CA, Charles SJ. Marfan syndrome: fibrillin expression and microfibrillar abnormalities in a family with predominant ocular defects. J Med Genet 1995;32:1-6.
30. Lee B, Godfrey M, Vitale E, et al. Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. Nature 1991;352:330-4.
31. Putnam EA, Zhang H, Ramirez F, Milewicz DM. Fibrillin-2 (FBN2) mutations result in the Marfan-like disorder, congenital contractural arachnodactyly. Nat Genet 1995;11:456-8.
32. Wang M, Clericuzio CL, Godfrey M. Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2. Am J Hum Genet 1996; 59:1027-34.
33. Liu W, Quian C, Comeau K, Brenn T, Furthmayr H, Francke U. Mutant fibrillin-1 monomers lacking EGF-like domains disrupt microfibril assembly and cause severe Marfan syndrome. Hum Mol Genet 1996;5:1581-7.
34. Pessier AP, Potter KA. Ocular pathology in bovine Marfan's syndrome with demonstration of altered fibrillin immunoreactivity in explanted ciliary body cells. Lab Invest 1996;75:87-95.
35. Fleischer KJ, Nousari HC, Anhalt GJ, Stone CD, Laschinger JC. Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome. Ann Thorac Surg 1997;63:1012-7.
36. Ljubimov AV, Burgeson RE, Butkowski RJ, Michael AF, Sun T-T, Kenney MC. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms. Lab Invest 1995;72:461-73.
37. Wright DW, McDaniels CN, Swasdison S, Accavitti MA, Mayne PM, Mayne R. Immunization with undenatured bovine zonular fibrils results in monoclonal antibodies to fibrillin. Matrix Biol 1994;14:41-9.
38. Reinhardt DP, Keene DR, Corson GM, et al. Fibrillin-1: organization in microfibrils and structural properties. J Mol Biol 1996; 258:104-16.
39. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990;215:403-10.
40. Ausubel FM, Brent R, Kingston RE, et al., eds. Current protocols in molecular biology, vol. 1. New York: John Wiley & Sons, 1994:2.9A-3.10.
41. Keene DR, Jordan CD, Reinhardt DP, et al. Fibrillin-1 in human cartilage: developmental expression and formation of special banded fibers. J Histochem Cytochem 1997;45:1069-82.
42. Rosenbloom J, Abrams WR, Mecham R. Extracellular matrix 4: the elastic fiber. FASEB J 1993;7:1208-18.
43. Reinhardt DP, Chalberg SC, Sakai LY. The structure and function of fibrillin. Ciba Found Symp 1995;192:128-43.
44. Sakai LY, Keene DR. Fibrillin: monomers and microfibrils. Methods Enzymol 1994;245:29-52.
45. Ashcroft GS, Kielty CM, Horan MA, Ferguson MW. Age-related changes in the temporal and spatial distributions of fibrillin and elastin mRNAs and proteins in acute cutaneous wounds of healthy humans. J Pathol 1997;183:80-9.
46. Maguen E, Alba SA, Burgeson RE, et al. Alterations of corneal extracellular matrix following multiple refractive procedures: clinical and immunohistochemical study. Cornea 1997;16:675-82.
47. Maguen E, Kenney MC, Alba SA, Ljubimov AV. Extracellular matrix changes in scars of human radial keratotomy corneas: ARVO abstracts. Invest Ophthalmol Vis Sci 1997;38:S209.
48. Kenney MC, Chwa M. Abnormal extracellular matrix in corneas with pseudophakic bullous keratopathy. Cornea 1990;9:115-21.
49. Zhang H, Hu W, Ramirez F. Developmental expression of fibrillin genes suggest heterogeneity of extracellular microfibrils. J Cell Biol 1995;129:1165-76.
50. Haynes SL, Shuttleworth CA, Kielty CM. Keratinocytes express fibrillin and assemble microfibrils: implications for dermal matrix organization. Br J Dermatol 1997;137:17-23.
51. Rosenbaum JT, Planck ST, Huang XN, Rich L, Ansel JC. Detection of mRNA for the cytokines, interleukin-1α and interleukin-8, in corneas from patients with pseudophakic bullous keratopathy. Invest Ophthalmol Vis Sci 1995;36:2151-5.
52. Werth VP, Williams KJ, Fisher EA, Bashir M, Rosenbloom J, Shi X. UVB irradiation alters cellular responses to cytokines: role in extracellular matrix gene expression. J Invest Dermatol 1997;108: 290-4.
53. Raphael B, Lange RB, Wood T, McLaughlin BJ. Growth of human corneal endothelium on altered Descemet's membrane. Cornea 1992;11:242-9.
54. Lauweryns B, van den Oord JJ, Missotten L. Localization of the cytoadhesin integrins in the human cornea: an immunohistochemical study using monoclonal antibodies. Graefes Arch Clin Exp Ophthalmol 1992;230:264-8.